The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.

Medera and Novoheart have collaborated with University of California San Diego School of Medicine and Mayo Clinic mini-heart ...

Acquisitions involving innovator drugs have grown year-on-year with total deal value increasing eight-fold to almost $18 ...

Revolution Medicines has partnered Royalty Pharma for $2bn to support development and commercialisation of its RAS(ON) ...

The US FDA has approved Sanofi and Regeneron’s Dupixent (dupilumab) as a treatment option for adults with bullous pemphigoid.

Membrane is a winner in the Innovation, Research & Development, and Environmental categories in the 2025 Pharmaceutical ...

Zambon Pharma has received approval from Chinese regulatory authorities and launched Fluimucil (N-acetylcysteine).

Navamedic has signed an agreement for the acquisition of Norwegian company dne pharma in a deal valued at Nkr225m ($22m).

Novo Nordisk has ended a partnership with telehealth company Him & Hers, after launching the collaboration less than two ...

The FDA's new genAI-assisted scientific review technology, named Elsa, was officially adopted by the agency on 2 June.

The FDA has approved AstraZeneca and Daiichi Sankyo's Datroway (Datopotamab deruxtecan) for adults with NSCLC.

The Pharmaceutical Technology Excellence Awards celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognize the people and companies that are ...